DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr |
What is the latest Total Non-Current Assets ratio of DIVIS LABORATORIES ?
Year | Total Non-Current Assets |
---|---|
Mar2025 | ₹6,840 Cr |
Mar2024 | ₹5,785 Cr |
Mar2023 | ₹5,113 Cr |
Mar2022 | ₹5,009 Cr |
Mar2021 | ₹4,596 Cr |
How is Total Non-Current Assets of DIVIS LABORATORIES Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹6,840 Cr | 18.24 | |
Mar2024 | ₹5,785 Cr | 13.14 | |
Mar2023 | ₹5,113 Cr | 2.08 | |
Mar2022 | ₹5,009 Cr | 8.97 | |
Mar2021 | ₹4,596 Cr | - |
Compare Total Non-Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹176,643.8 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
MANKIND PHARMA | ₹107,349.0 Cr | -1.5% | 12.7% | 26.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2% |
1.3% |
45.8% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses